News about Bio-Techne Corp (TECH) revolves around its business moves, financial results, strategic partnerships, and analyst predictions. It has a consistent presence at significant conferences, such as the Society for Immunotherapy of Cancer (SITC) Annual Meeting and Neuroscience 2024. Other notable highlights include strategic investments in companies like SPEAR BIO and WILSON WOLF MANUFACTURING. The company's earnings have been fluctuating, leading to mixed responses from investors and analysts. However, it managed to beat quarterly profit estimates as well as top Q1 Earnings & Revenue. In terms of corporate governance, executive compensation and changes have been announced. There have also been sales of TECH shares by entities such as Van ECK Associates Corp, Asset Management One Co. Ltd., and New York State Common Retirement Fund. Dividends were declared, despite a zero growth rate in the past half-decade. Furthermore, despite some losses for investors, analysts have given TECH a moderate buy recommendation.
Bio-Techne Corp TECH News Analytics from Mon, 22 Nov 2021 08:00:00 GMT to Sat, 09 Nov 2024 01:38:10 GMT - Rating 2 - Innovation 6 - Information 7 - Rumor 0
